Ausgabe 3/2013
Including PIH Articles on Basic and Clinical Updates in Multiple Myeloma
Inhalt (22 Artikel)
Hypopyon as the first sign of relapse in acute lymphoblastic leukaemia
Daniela Barraco, Anna Candoni, Erica Simeone, Angelo Pirracchio, Renato Fanin
Guest editorial: basic and clinical updates in multiple myeloma
Masahiro Kizaki
Molecular pathogenesis of multiple myeloma: basic and clinical updates
Marta Chesi, P. Leif Bergsagel
Histone deacetylase inhibitors in the treatment for multiple myeloma
Teru Hideshima, Kenneth C. Anderson
Current approaches for the treatment of multiple myeloma
Reiko Watanabe, Michihide Tokuhira, Masahiro Kizaki
Presence of antiphospholipid antibody is a risk factor in thrombotic events in patients with antiphospholipid syndrome or relevant diseases
Koji Habe, Hideo Wada, Takeshi Matsumoto, Kohshi Ohishi, Makoto Ikejiri, Kimiko Matsubara, Tatsuhiko Morioka, Yuki Kamimoto, Tomoaki Ikeda, Naoyuki Katayama, Tsutomu Nobori, Hitoshi Mizutani
A randomized dose-escalation study to assess the safety, tolerability, and pharmacokinetics of ruxolitinib (INC424) in healthy Japanese volunteers
Yoichiro Ogama, Tomoko Mineyama, Asuka Yamamoto, Margaret Woo, Naomi Shimada, Taro Amagasaki, Kazuto Natsume
Open-label, dose-titration and continuation study to assess efficacy, safety, and pharmacokinetics of anagrelide in treatment-naïve Japanese patients with essential thrombocythemia
Shinichiro Okamoto, Yoshitaka Miyakawa, Jonathan Smith, Ian Hodgson, Brihad Abhyankar, Steven Troy, Yuzuru Kanakura
Clinical significance of jejunoileal involvement of non-Hodgkin’s lymphoma detected by double-balloon enteroscopy
Takashi Ibuka, Hisashi Tsurumi, Hiroshi Araki, Takeshi Hara, Fumito Onogi, Naoe Goto, Yasushi Kojima, Nobuhiro Kanemura, Makoto Shiraki, Senji Kasahara, Masahito Shimizu, Kengo Ogawa, Soranobu Ninomiya, Takayuki Nakanishi, Tomohiro Kato, Tsuyoshi Takami, Hisataka Moriwaki
Lymphocytopenia is associated with an increased risk of severe infections in patients with multiple myeloma treated with bortezomib-based regimens
Sung-Hoon Jung, Soo-Young Bae, Jae-Sook Ahn, Seung-Ji Kang, Deok-Hwan Yang, Yeo-Kyeoung Kim, Hyeoung-Joon Kim, Je-Jung Lee
Inclusion of hemoglobin level in prognostic score provides better prognostic stratification in patients with acute promyelocytic leukemia (APL)
Silvia Park, Su Jin Lee, Kihyun Kim, Jun Ho Jang, Dong Hwan Kim, Kyu Hyung Lee, Je Hwan Lee, Jung Hee Lee, Dae Young Kim, Dae-Young Jang, Hawk Kim, Jae Hoo Park, Hun Mo Ryoo, Sung Hwa Bae, Min Kyung Kim, Myung Soo Hyun, Young Don Joo, Won Sik Lee, Sang Min Lee, Chul Won Jung
Prognostic value of Waldeyer’s ring involvement of diffuse large B-cell lymphoma treated with R-CHOP
Min-Young Oh, Joo-Seop Chung, Moo-Kon Song, Ho-Jin Shin, Ho-Sup Lee, Sang-Min Lee, Gyeong-Won Lee, Su-Ee Lee
Chronic lymphocytic leukemia in Korean patients: frequent atypical immunophenotype and relatively aggressive clinical behavior
Mi-Ae Jang, Eun-Hyung Yoo, Kihyun Kim, Won Seog Kim, Chul Won Jung, Sun-Hee Kim, Hee-Jin Kim
JAK2 46/1 haplotype is associated with JAK2 V617F-positive myeloproliferative neoplasms in Japanese patients
Mayumi Tanaka, Toshiaki Yujiri, Shunsuke Ito, Naoko Okayama, Toru Takahashi, Kenji Shinohara, Yoichi Azuno, Ryouhei Nawata, Yuji Hinoda, Yukio Tanizawa
Risk factors influencing mortality related to Stenotrophomonas maltophilia infection in hematology–oncology patients
Hayati Demiraslan, Mustafa Sevim, Çiğdem Pala, Süleyman Durmaz, Veli Berk, Leylagül Kaynar, Gökhan Metan
Diagnosis and evaluation of intestinal graft-versus-host disease after allogeneic hematopoietic stem cell transplantation following reduced-intensity and myeloablative conditioning regimens
Satoshi Yamasaki, Akiko Miyagi-Maeshima, Yasuo Kakugawa, Yoshihiro Matsuno, Fusako Ohara-Waki, Shigeo Fuji, Yuriko Morita-Hoshi, Masakazu Mori, Sung-Won Kim, Shin-ichiro Mori, Takahiro Fukuda, Ryuji Tanosaki, Tadakazu Shimoda, Kensei Tobinai, Daizo Saito, Yoichi Takaue, Takanori Teshima, Yuji Heike
Successful treatment of a pregnant woman with Philadelphia chromosome-positive acute lymphoblastic leukemia
Yuki Nakajima, Hideyuki Kuwabara, Yukako Hattori, Rika Ohshima, Rika Sakai, Masakazu Kitagawa, Naoto Tomita, Yoshiaki Ishigatsubo, Shin Fujisawa
Diffuse panbronchiolitis after humanized anti-CCR4 monoclonal antibody therapy for relapsed adult T-cell leukemia/lymphoma
Koji Kato, Toshihiro Miyamoto, Akihiko Numata, Takashi Nakaike, Hideyo Oka, Ayano Yurino, Takuro Kuriyama, Yasuo Mori, Satoshi Yamasaki, Tsuyoshi Muta, Katsuto Takenaka, Hiromi Iwasaki, Takanori Teshima, Koichi Akashi
Acute abdomen due to splenic infarction as the initial presentation of pediatric acute lymphoblastic leukemia
Uttam Kumar Nath, Siddhartha Sankar Ray, Arnab Chattopadhyay, Prantar Chakrabarti, Utpal Chaudhuri
JAK2 V617F mutation positive primary myelofibrosis with concomitant t(9;11;22)(q34;p15;q11.2) but no BCR/ABL fusion
Wing-Yan Au, Thomas S. K. Wan, Edmond S. K. Ma
Distinct efficacy of pegylated-interferon α2a and α2b during treatment of essential thrombocythemia
Nicolas Noel, Jean-Marie Michot, Caroline Besson, Cécile Goujard, Olivier Lambotte